Markus Kohlmann

Targeting DnaN for tuberculosis therapy using novel griselimycins

Angela Kling, Peer Lukat, Deepak V. Almeida et al. · Science · 2015 · 309 citations

Streptomyces-produced Streptomycin, Antibiotic Adjuvant, Tuberculosis Prevention +18

Pharmacological Characterization of SAR407899, a Novel Rho-Kinase Inhibitor

Matthias Löhn, Oliver Plettenburg, Yuri Ivashchenko et al. · Hypertension · 2009 · 86 citations

Formation of lipoxygenase‐pathway‐derived aldehydes in barley leaves upon methyl jasmonate treatment

Markus Kohlmann, Astrid Bachmann, Heiko Weichert et al. · European Journal of Biochemistry · 1999 · 72 citations

Additive efficacy of a bispecific anti–TNF/IL-6 nanobody compound in translational models of rheumatoid arthritis

Nadine Biesemann, Daniel Margerie, Christian Asbrand et al. · Science Translational Medicine · 2023 · 61 citations

Novel β-Amino Acid Derivatives as Inhibitors of Cathepsin A

Sven Ruf, Christian Buning, Herman Schreuder et al. · Journal of Medicinal Chemistry · 2012 · 46 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Cathepsin A +12